A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Prestige Consumer Healthcare Inc.
PBH
$2.4B
Mkt Cap
$49.66
+1.47%
Prestige Consumer Healthcare Inc. (PBH) has a current P/E ratio of 13.1, compared to its historical median P/E of 13.9. The stock is currently considered Fair based on its historical valuation range.
Prestige Consumer Healthcare Inc. (PBH) has a 5-year average return on invested capital (ROIC) of 7.0%. This is below average and may indicate limited pricing power.
Prestige Consumer Healthcare Inc. (PBH) has a market capitalization of $2.4B. It is classified as a mid-cap stock.
Prestige Consumer Healthcare Inc. (PBH) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 6.47%.
Based on historical P/E analysis, Prestige Consumer Healthcare Inc. (PBH) appears fair. The current P/E of 13.1 is 5% below its historical median of 13.9. The estimated fair value CAGR (P/E method) is 14.7%.
Prestige Consumer Healthcare Inc. (PBH) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Unless otherwise indicated by the context, all references in this Annual Report on Form 10-K to “we,” “us,” “our,” the “Company” or “Prestige” refer to Prestige Consumer Healthcare Inc. and our subsidiaries. Prior to August 17, 2018, the Company's name was Prestige Brands Holdings, Inc. Reference to a year (e.g., “2025”) refers to our fiscal year ended March 31 of that year. We formed as a Delaware corporation in 1996 and are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name, over-the-counter (“OTC”) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. We use the strength of our brands, our established retail distribution network, a low-cost operating model and our experienced management team to our competitive advantage.
| Metric | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Net Income | 190M | 190M | 215M | 209M | -82M | 205M |
| EPS | $3.91 | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Free Cash Flow | 246M | 246M | 243M | 239M | 222M | 250M |
| ROIC | 8.1% | 8.2% | 9.3% | 9.5% | -0.8% | 8.8% |
| Gross Margin | 54.7% | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% |
| Debt/Equity | 0.53 | 0.53 | 0.54 | 0.68 | 0.93 | 0.94 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 309M | 309M | 337M | 342M | -22M | 330M |
| Operating Margin | 28.4% | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| ROE | 10.1% | 10.2% | 12.3% | 13.5% | -5.4% | 14.0% |
| Shares Outstanding | 49M | 49M | 50M | 50M | 50M | 51M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 713M | 806M | 882M | 1.0B | 976M | 963M | 943M | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Gross Margin | 56.9% | 57.9% | 56.7% | 55.4% | 56.9% | 57.3% | 58.0% | 57.1% | 55.4% | 55.5% | 55.8% | 54.7% | 54.7% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 81M | 72M | 89M | 85M | 90M | 89M | 83M | 107M | 107M | 106M | 108M | 116M | 116M |
| EBIT | 208M | 260M | 206M | 215M | 68M | 291M | 297M | 330M | -22M | 342M | 337M | 309M | 309M |
| Op. Margin | 29.1% | 32.3% | 23.3% | 20.7% | 6.9% | 30.2% | 31.5% | 30.4% | -2.0% | 30.4% | 29.6% | 28.4% | 28.4% |
| Net Income | 78M | 100M | 69M | 340M | -36M | 142M | 165M | 205M | -82M | 209M | 215M | 190M | 190M |
| Net Margin | 11.0% | 12.4% | 7.9% | 32.6% | -3.7% | 14.8% | 17.5% | 18.9% | -7.3% | 18.6% | 18.9% | 17.5% | 17.5% |
| Non-Recurring | 1.1M | 35K | -573K | -1.6M | 33M | -713K | 1.0M | 69K | 49M | -274K | 12M | -165K | -165K |
| Returns on Capital | |||||||||||||
| ROIC | 7.0% | 7.3% | 4.8% | 7.0% | 2.2% | 7.6% | 8.5% | 8.8% | -0.8% | 9.5% | 9.3% | 8.2% | 8.1% |
| ROE | 13.1% | 14.6% | 8.9% | 33.9% | -3.1% | 12.6% | 13.0% | 14.0% | -5.4% | 13.5% | 12.3% | 10.2% | 10.1% |
| ROA | 3.5% | 3.6% | 2.0% | 8.9% | -1.0% | 4.1% | 4.7% | 5.8% | -2.3% | 6.3% | 6.4% | 5.5% | 5.4% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 156M | 176M | 149M | 210M | 189M | 217M | 236M | 260M | 230M | 249M | 252M | 258M | 258M |
| Free Cash Flow | 150M | 173M | 146M | 198M | 179M | 203M | 213M | 250M | 222M | 239M | 243M | 246M | 246M |
| Owner Earnings | 132M | 143M | 115M | 168M | 150M | 180M | 197M | 219M | 185M | 204M | 210M | 216M | 216M |
| CapEx | 6.1M | 3.6M | 3.0M | 13M | 10M | 15M | 22M | 9.6M | 7.8M | 9.5M | 8.2M | 11M | 11M |
| Maint. CapEx | 18M | 24M | 26M | 33M | 32M | 29M | 30M | 32M | 33M | 31M | 30M | 31M | 31M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 18M | 24M | 26M | 33M | 32M | 29M | 30M | 32M | 33M | 31M | 30M | 31M | 31M |
| CapEx/OCF | 3.9% | 2.0% | 2.0% | 6.0% | 5.5% | 6.7% | 9.4% | 3.7% | 3.4% | 3.8% | 3.3% | N/A | 4.3% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 50M | 57M | 12M | 0 | 50M | 25M | 52M | 156M | 156M |
| Buyback Yield | N/A | N/A | N/A | N/A | 3.2% | 3.0% | 0.5% | N/A | 1.6% | 0.7% | 1.2% | 0.0% | 6.5% |
| Stock-Based Comp | 6.9M | 10.0M | 8.1M | 8.9M | 7.4M | 7.6M | 8.5M | 9.0M | 12M | 14M | 11M | 11M | 11M |
| Debt Repayment | 0 | 80M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 1.5B | 1.6B | 2.2B | 2.0B | 1.8B | 1.6B | 1.4B | 1.5B | 1.3B | 1.1B | 897M | 933M | 933M |
| Cash & Equiv. | 21M | 27M | 42M | 33M | 28M | 95M | 32M | 27M | 58M | 46M | 98M | 64M | 64M |
| Long-Term Debt | 1.6B | 1.6B | 2.2B | 2.0B | 1.8B | 1.7B | 1.5B | 1.5B | 1.3B | 1.1B | 992M | 994M | 994M |
| Debt/Equity | 2.49 | 2.18 | 2.67 | 1.69 | 1.64 | 1.48 | 1.09 | 0.94 | 0.93 | 0.68 | 0.54 | 0.53 | 0.53 |
| Interest Coverage | 2.6 | 3.1 | 2.2 | 2.0 | 0.6 | 3.0 | 3.6 | 5.1 | -5.1 | 65.9 | 187.1 | 7.3 | 7.3 |
| Equity | 628M | 744M | 823M | 1.2B | 1.1B | 1.2B | 1.4B | 1.6B | 1.4B | 1.7B | 1.8B | 1.9B | 1.9B |
| Total Assets | 2.6B | 2.9B | 3.9B | 3.8B | 3.4B | 3.5B | 3.4B | 3.7B | 3.4B | 3.3B | 3.4B | 3.5B | 3.5B |
| Total Liabilities | 2.0B | 2.2B | 3.1B | 2.6B | 2.3B | 2.3B | 2.1B | 2.1B | 1.9B | 1.7B | 1.6B | 1.6B | 1.6B |
| Intangibles | 2.1B | 2.3B | 2.9B | 2.8B | 2.5B | 2.5B | 2.5B | 2.7B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B |
| Retained Earnings | 227M | 327M | 397M | 736M | 702M | 844M | 1.0B | 1.2B | 1.1B | 1.3B | 1.6B | 1.7B | 1.7B |
| Working Capital | 103M | 142M | 172M | 180M | 174M | 216M | 148M | 150M | 231M | 258M | 342M | 311M | 311M |
| Current Assets | 202M | 249M | 334M | 303M | 301M | 366M | 270M | 293M | 392M | 375M | 448M | 431M | 431M |
| Current Liabilities | 99M | 107M | 162M | 123M | 127M | 150M | 122M | 143M | 161M | 117M | 107M | 121M | 121M |
| Per Share Data | |||||||||||||
| EPS | 1.49 | 1.88 | 1.30 | 6.34 | -0.69 | 2.78 | 3.25 | 4.04 | -1.65 | 4.17 | 4.29 | 3.91 | 3.91 |
| Owner EPS | 2.51 | 2.68 | 2.15 | 3.13 | 2.89 | 3.53 | 3.89 | 4.30 | 3.70 | 4.07 | 4.20 | 4.43 | 4.43 |
| Book Value | 11.95 | 14.01 | 15.41 | 22.01 | 21.12 | 22.88 | 26.81 | 31.03 | 29.01 | 32.97 | 36.68 | 38.78 | 38.78 |
| Cash Flow/Share | 2.97 | 3.32 | 2.79 | 3.92 | 3.65 | 4.24 | 4.65 | 5.11 | 4.61 | 4.96 | 5.03 | 5.29 | 4.55 |
| Dividends/Share | 0.00 | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 52.5M | 53.1M | 53.4M | 53.6M | 51.9M | 51.2M | 50.7M | 50.8M | 49.9M | 50.2M | 50.0M | 48.7M | 48.7M |
| Valuation | |||||||||||||
| P/E Ratio | 28.5 | 27.1 | 43.4 | 5.4 | N/A | 13.1 | 13.9 | 13.3 | N/A | 17.4 | 19.8 | N/A | 12.7 |
| P/FCF | 14.8 | 15.7 | 20.6 | 9.3 | 8.6 | 9.2 | 10.7 | 10.9 | 14.1 | 15.2 | 17.5 | N/A | 9.8 |
| EV/EBIT | 18.1 | 16.5 | 24.9 | 17.5 | 48.7 | 11.7 | 12.5 | 12.6 | N/A | 13.7 | 15.0 | N/A | 10.8 |
| Price/Book | 3.6 | 3.6 | 3.7 | 1.6 | 1.4 | 1.6 | 1.7 | 1.7 | 2.2 | 2.2 | 2.3 | N/A | 1.3 |
| Price/Sales | 2.5 | 3.1 | 3.2 | 2.4 | 1.8 | 1.8 | 2.1 | 2.6 | 2.5 | 2.7 | 3.3 | N/A | 2.2 |
| FCF Yield | 6.7% | 6.4% | 4.8% | 10.7% | 11.6% | 10.9% | 9.3% | 9.1% | 7.1% | 6.6% | 5.7% | N/A | 10.2% |
| Market Cap | 2.2B | 2.7B | 3.0B | 1.8B | 1.5B | 1.9B | 2.3B | 2.7B | 3.1B | 3.6B | 4.3B | 0 | 2.4B |
| Avg. Price | 34.03 | 47.37 | 52.23 | 47.41 | 34.23 | 34.65 | 38.55 | 54.91 | 57.43 | 61.60 | 74.41 | 0.00 | 49.66 |
| Year-End Price | 42.43 | 51.04 | 56.36 | 34.40 | 29.78 | 36.40 | 45.05 | 53.81 | 62.66 | 72.56 | 85.09 | 0.00 | 49.66 |
Prestige Consumer Healthcare Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
Prestige Consumer Healthcare Inc. trades at 13.1x trailing earnings, compared to its 15-year median P/E of 13.9x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 8.8x vs a median of 10.9x. The company's 5-year average ROIC is 7.0% with a gross margin of 55.7%. Total shareholder yield (buybacks) is 6.5%. At current prices, the estimated annualized return to fair value is +5.2%.
Prestige Consumer Healthcare Inc. (PBH) reported annual revenue of $1.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Prestige Consumer Healthcare Inc. (PBH) has a net profit margin of 17.5%. This is a healthy margin.
Prestige Consumer Healthcare Inc. (PBH) generated $246 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Prestige Consumer Healthcare Inc. (PBH) has a debt-to-equity ratio of 0.53. This indicates moderate leverage.
Prestige Consumer Healthcare Inc. (PBH) reported earnings per share (EPS) of $3.91 in its most recent fiscal year.
Prestige Consumer Healthcare Inc. (PBH) has a return on equity (ROE) of 10.2%. This indicates moderate shareholder returns.
Prestige Consumer Healthcare Inc. (PBH) has a 5-year average gross margin of 55.7%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for Prestige Consumer Healthcare Inc. (PBH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Prestige Consumer Healthcare Inc. (PBH) has a book value per share of $38.78, based on its most recent annual SEC filing.